• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group

    Author

    • Pusala Venkatanarayana
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: Platelets play a vital role in hemostasis. Idiopathic / Immune
thrombocytopenic purpura (ITP) is a common bleeding disorder in children, where
autoantibodies mediated consumption of the platelets, suppression of platelet
production by bone marrow megakaryocytes leads to thrombocytopenia and bleeding
manifestations. Incidence is 6.4 per 10000 among children and 3.3 per 10000 adults per
year.1 There is highest male to female ratio in infancy and it decreases with older age
groupchildren. No significant seasonal variation. Vaccination may play an important
role in the etiology of ITP in infants. History of a preceding viral infection 1-6 weeks
before the onset disease is present in 60% of cases. Bone. narrow was routinely
performed but evidences confirmedthat its rarely needed at presentation, must be
considered if having severe bleeding or not responding to treatment.
Materials &Methods:Details about children with ITP who presented to our hospital
between October 2020 and August 2021 were collected using a proforma. The study was
designed as a cross-sectional study. To meet the sample size, convenience sampling was
used.
Results: Total number of children recruited with a clinical diagnosis of primary itp was
120 after excluding the ones which had a secondary cause identified, the total primary
itp studied were 100. among them based on the duration of symptoms (as per
definitions) they were categorized into newly diagnosed, persistent and chronic itp.
There were 46 cases of chronic itp and 44 cases of persistent ITP. 73 percent of all
patients were between the ages of 1 and 10 years. in total, 8.9 percent of them had severe
bleeds. there was no link discovered between bleeding and platelet count. a high nordic
score (10-14) had a high predictability for short-term symptoms.
Conclusion: In our study, there was a higher incidence of its presenting in the hospital.
Higher a percentage of them had severe bleeding.

Keywords

  • Immune thrombocytopenia
  • Bleeding
  • nordic score
  • Platelet
  • fatal clinical haemorrhages
  • XML
  • PDF 314.84 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 108
    • PDF Download: 215
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 1966-1976
Files
  • XML
  • PDF 314.84 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 108
  • PDF Download: 215

APA

Venkatanarayana, P. (2022). Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group. European Journal of Molecular & Clinical Medicine, 9(3), 1966-1976.

MLA

Pusala Venkatanarayana. "Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1966-1976.

HARVARD

Venkatanarayana, P. (2022). 'Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1966-1976.

VANCOUVER

Venkatanarayana, P. Clinical Profile of Immune Thrombocytopenic Purpura in Paediatric age Group. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1966-1976.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus